ACTRN12619001175167已完成未知
A multi-site, parallel group, two-arm randomised controlled trial to test the effectiveness of using a Meditation App in managing occupational stress among ED staff – Trial Protocol
niversity of Queensland0 个研究点目标入组 148 人开始时间: 2019年8月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 148
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Either permanent or causal staff in the EDs
- •Have a daily access to a smartphone with Internet access`
- •Able to commit to the four weeks intervention period
排除标准
- •Agency staff or external staff
- •Self-reported with a previous diagnosis of psychiatric disease(s) or severe depression
- •Have practiced meditation or yoga regularly (practice at least once a week) in the past three months
研究者
相似试验
暂停
3 期
A Phase III study to investigate the effect of EMD-RX5 on symptoms of psychological distress in adults with chronic paiACTRN12622001319763Emyria Ltd300
终止
3 期
Effect of opioids on outcomes of pulmonary rehabilitatioChronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseasePhysical Medicine / Rehabilitation - PhysiotherapyACTRN12615000121561Flinders University260
进行中（未招募）
1 期
A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasomotor symptoms associated with the menopausemoderate to severe vasomotor symptoms associated with the menopauseMedDRA version: 7.0 Level: LLT Classification code 10020411EUCTR2004-000472-14-ESV Organon900
进行中（未招募）
不适用
A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasomotor symptoms associated with the menopausetreatment of moderate to severe vasomotor symptomsMedDRA version: 6.1Level: PTClassification code 10027304EUCTR2004-000469-36-ITORGANON ITALIA
进行中（未招募）
1 期
A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasomotor symptoms associated with the menopause - N/AEUCTR2004-000469-36-FIV Organon900